Imaging Studies of Patients with Malignant Fibrous Histiocytoma Using C-11-Alpha-Aminoisobutyric Acid (AIB)

Authors:
  • BSBernard Schmall
    Bernard Schmall
  • PCPeter S. Conti
    Peter S. Conti
  • RBRodney E. Bigler
    Rodney E. Bigler
  • PZPat B. Zanzonico
    Pat B. Zanzonico
  • RRRobert E. Reiman
    Robert E. Reiman
  • RBRichard S. Benua
    Richard S. Benua
  • SYSamuel D. J. Yeh
    Samuel D. J. Yeh
  • JDJ Robert Dahl
    J Robert Dahl
  • RLRichard Lee
    Richard Lee
  • JLJohn S. Laughlin
    John S. Laughlin

Abstract
Alpha-aminoisobutyric acid (AIB), a synthetic, nonmetabolized amino acid which is rapidly transported into viable cells by the A-type or alanine-preferring amino acid transport system, has been labeled with the shortlived, positron-emitting radionuclide carbon-11. Carbon-11 labeled AIB is currently being evaluated as a tumor imaging agent for in vivo amino acid transport studies in patients with cancer. In this study, C-11 AIB was used to image two patients with malignant fibrous histiocytoma (MFH), a pleomorphic sarcoma. Following intravenous administration of C-11 AIB, tumors in the distal femur of one patient and in the anterior chest wall of another patient were well visualized using high energy gamma scintigraphy. Since therapy may alter the accumulation of amino acids in tumor tissue, studies using C-11 AIB in patients with MFH before and after chemotherapy are in progress.